Choose date and time: ×
In the last half-hour
In the last hour
Gilead's HCV NDA Means Nothing Seeking Alpha 18:35
In the last 2 hours
In the last 4 hours
In the last 6 hours
Is Celgene a Buffett Stock? The Motley Fool 14:12
In the last 8 hours
Earlier today
Rejuvenating the Chance of Motherhood? MIT Technology Review 05:05
World Enzymes Market MarketWatch 04:08
Mason college student runs biotech startup 23:26 8-Dec-16
The 3 Best Biotech Stocks for 2017 The Motley Fool 21:25 8-Dec-16
Why Is AbbVie A Strong Buy In 2016? : Part 2 Seeking Alpha 19:51 8-Dec-16
Thursday's ETF Movers: ITB, XBI Nasdaq 19:00 8-Dec-16
Meet the World’s First Completely Soft Robot MIT Technology Review 15:09 8-Dec-16
Should Geron Opt-In? Seeking Alpha 14:53 8-Dec-16
Gilead Sciences: We Can Get Past This… Barron's Online 14:52 8-Dec-16
Cempra: A Revealing SWOT Analysis Seeking Alpha 14:13 8-Dec-16
Donald Trump Vows To Reduce Drug Prices, Doesn't Say How The Huffington Post (US) 14:04 8-Dec-16
Knowing when an MRI scan can help The Biotech Weblog 13:51 8-Dec-16
Indian pharma industry facing growth headwinds: ICRA The Times of India 11:17 8-Dec-16
Cipla gets USFDA nod for Hepatitis B treatment drug The Times of India 07:16 8-Dec-16
Meet the Octobot MIT Technology Review 05:05 8-Dec-16
In the last 7 days
Why bluebird bio Inc. Slipped Lower Today The Motley Fool 22:05 7-Dec-16
PTC Therapeutics, Inc. in 3 Charts The Motley Fool 21:45 7-Dec-16
Sage Therapeutics: Timeline Of The Debate Seeking Alpha 21:16 7-Dec-16
Trump comments slam drug stocks Reuters 20:13 7-Dec-16

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • This site uses cookies. To see how, read our Privacy and Cookie Notice. If you disagree with our use of cookies, please navigate away.
Sorry, no headlines or news topics were found. Please try different keywords.